Nisar Ahmed Khan

This inventor holds 20 USPTO granted patents and 5 published patent applications, plus 3 CIPO patents and 5 EPO patents, primarily in Immunotherapy Research. Top assignees: Biotempt B.v., Erasmus University Rotterdam, Biotemp B.v.. Active years: 2005-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nisar Ahmed Khan. Retrieved from https://idiyas.com/inventor/nisar-ahmed-khan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 20 (Patent Applications = 5)

% Patents Active = 45.0

CIPO Patents = 3 (Patent Applications = 1)

EPO Patents = 5 (Patent Applications = 5)

Average Co-Inventor Count = 2.3

ph-index = 10

Forward Citations = 192(Granted Patents)

Company Filing History:

Erasmus University Rotterdam

Years Active: 2005-2014

Loading Chart...

Areas of Expertise:

Oligopeptide Acetate

Immunoregulatory Compositions

Radiation Injury Control

Ischemic Events Treatment

Blood Urea Reduction

Tumor Treatment

Multiple Sclerosis

Type I Diabetes

Transplant Survival

Septic Shock

Therapeutic Compounds

Peptide Selection

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8680059 - Oligopeptide acetate and formulations thereof (2014-03-25),

2. 8288341 - Control of radiation injury (2012-10-16),

3. 8216998 - Treatment of ischemic events (2012-07-10),

4. RE43309 - Immunoregulatory compositions (2012-04-09),

5. RE43279 - Compositions capable of reducing elevated blood urea concentration (2012-03-26),

6. RE43140 - Immunoregulator (2012-01-23),

7. 7820617 - Methods of selecting immunoregulator peptides obtained from gonadotropins (2010-10-26),

8. 7795226 - Control of radiation injury (2010-09-14),

9. 7786084 - Treatment of burns (2010-08-31),

10. 7662776 - Treatment of tumors using short peptides from human chorionic gonadotropin (HCG) (2010-02-16),

11. 7576174 - Compositions capable of reducing elevated blood urea concentration (2009-08-18),

12. 7560433 - Treatment of multiple sclerosis (MS) (2009-07-14),

13. 7524820 - Compounds of therapeutic value in the treatment of multiple sclerosis and other diseases wherein foamy cells are involved in the disease etiology (2009-04-28),

14. 7517529 - Treatment of type I diabetes (2009-04-14),

15. 7501391 - Treatment of transplant survival (2009-03-10),

Title: Innovations by Nisar Ahmed Khan: A Pioneer in Pharmaceutical Patents

Introduction

Nisar Ahmed Khan is a prominent inventor based in Rotterdam, NL, known for his significant contributions to the field of pharmaceuticals. With an impressive portfolio of 20 patents, Nisar has carved a niche for himself in innovative treatments aimed at tackling severe health conditions.

Latest Patents

Among Nisar's latest patents are groundbreaking inventions such as "Oligopeptide Acetate and Formulations Thereof." This invention focuses on acetates of the tetrapeptides AQGV and LQGV, presenting pharmaceutical compositions that aim to treat acute inflammatory conditions, including sepsis. Another notable patent is "Control of Radiation Injury," which describes methods for treating radiation injuries through the administration of specific peptides. These innovations highlight Nisar's dedication to advancing medical treatments for critical health challenges.

Career Highlights

Throughout his career, Nisar has collaborated with leading institutions, notably Biotempt B.V. and Erasmus University Rotterdam. These affiliations have enabled him to enhance his research and development capabilities, bringing his innovative ideas to fruition and securing multiple patents.

Collaborations

Nisar has worked alongside esteemed colleagues such as Robbert Benner and Gert Wensvoort. Their collaborative efforts have further enriched his research endeavors, contributing to successful patent applications and innovative product development.

Conclusion

Nisar Ahmed Khan stands out as a remarkable inventor in the realm of pharmaceuticals. His extensive patent portfolio and collaborations with esteemed organizations emphasize his role as a significant contributor to medical innovation. With ongoing research and development, Nisar's inventions continue to pave the way for future advancements in treating complex health issues.

Profile summary based on public USPTO records.